We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Envision Healthcare Corporation (NYSE: EVHC) to the investment firm KKR. Under the terms of the transaction, Envision shareholders will receive $46 in cash per share.
The investigation concerns whether the Board of Envision breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether KKR is underpaying for Envision shares, thus unlawfully harming Envision shareholders.
To receive more information, please fill out the form.